Both IL-10 and IL-1 have pro-inflammatory effects in systemic lupus erythematosus and during inflammation or autoimmune diseases, and IL-10 inhibits the production of IL-1 by monocytes, macrophages, etc. [88], which provides evidence for the lower level of IL-1 in the control group compared to the experimental group. Here, IL1B is linked to autoimmune disease.